000			01606nam a2200229Ia 4500
003			MX-MdCICY
005			20250625153915.0
040			_cCICY
090			_aB-13069
245	1	0	_aNanocarriers as an emerging platform for cancer therapy
490	0		_vNature Nanotechnology, 2, p.751-760, 2007
520	3		_a1Immune Disease Institute and Department of Anesthesia, Harvard Medical School, Boston, Massachusetts 02115, USA; 2HST Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts 02139, USA; 3Harvard-MIT Division of Health Sciences and echnology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; 4Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; 5Laboratory of Nanomedicine and Biomaterials and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; 6Department of Biochemistry, George S. Wise Faculty of Life Sciences, and the Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 69978, Israel +These authors contributed equally to this review
700	1	2	_aPeer, D.
700	1	2	_aKarp, J.M.
700	1	2	_aHong, S.
700	1	2	_aFarokhzad, O.C.
700	1	2	_aMargalit, R.
700	1	2	_aLanger, R.
856	4	0	_uhttps://drive.google.com/file/d/1rmQBnD1Gtu0cLnMwnirjzVKW1l0plS-R/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c47271 _d47271